man in lab with large gloves

Areas of Focus

Accelerating new approaches to treat disease

We focus on a core set of therapeutic areas — ones where we've proven our expertise and where we have even greater potential to improve how diseases and conditions are managed. These include oncology, immunology, neuroscience, eye care, aesthetics and other areas of unmet need.

Areas of Focus: At a Glance


Immunology

We're building on our deep expertise and legacy in immunology research to explore new disease areas, create a more patient-centric discovery and development process and offer solutions for more diverse patient populations.

Oncology

We leverage our deep understanding of human biology and cutting-edge research technologies to find new ways to improve the lives of people with cancer. AbbVie is committed to drive solutions across oncology and to pioneer research to transform the standard of care for patients.

Neuroscience

Our scientists are relentless in their pursuit of raising the standards of care for neurological diseases and disorders.With more than three decades of experience in neuroscience, we are providing meaningful treatment options today and advancing innovation for the future.

Eye care

Our innovative portfolio and pipeline of new discoveries seek to maintain vision and prevent blindness. We are focused on improving the standards of care across multiple disease areas from the front to the back of the eye, from glaucoma to chronic retinal diseases.

Aesthetics

We create products and technologies that advance aesthetic medicine. Our aesthetics R&D team seeks to discover and accelerate comprehensive, evidence-based solutions focused on novel indications, improved delivery technologies and enhanced patient outcomes.

Other focus areas

Beyond our core areas, our research is also focused on infectious diseases — like Hepatitis C, endocrinology, diseases of the gastrointestinal tract and therapeutic neurotoxins. In these areas, a diverse set of scientific expertise is united by one vision — we believe impactful new discoveries for some of these patients are achievable.